Sanofi Adr Stock Analysis

SNY Stock  USD 54.50  0.51  0.94%   
Sanofi ADR is fairly valued with Real Value of 55.88 and Target Price of 63.06. The main objective of Sanofi ADR stock analysis is to determine its intrinsic value, which is an estimate of what Sanofi ADR is worth, separate from its market price. There are two main types of Sanofi ADR's stock analysis: fundamental analysis and technical analysis.
The Sanofi ADR stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Sanofi ADR is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Sanofi Stock trading window is adjusted to America/New York timezone.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Sanofi Stock Analysis Notes

The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi ADR has Price/Earnings To Growth (PEG) ratio of 1.18. The entity last dividend was issued on the 9th of May 2024. The firm had 5:1 split on the 30th of September 2013. Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 95442 people. To find out more about Sanofi ADR contact Paul Hudson at 33 1 53 77 40 00 or learn more at https://www.sanofi.com.

Sanofi ADR Quarterly Total Revenue

14.16 Billion

Sanofi ADR Investment Alerts

Sanofi ADR is unlikely to experience financial distress in the next 2 years
Sanofi ADR has a strong financial position based on the latest SEC filings
Latest headline from gurufocus.com: AMUNDIs Strategic Acquisition of Sanofi SA Shares A Detailed Analysis

Sanofi ADR Upcoming and Recent Events

Earnings reports are used by Sanofi ADR to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
1st of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Sanofi Largest EPS Surprises

Earnings surprises can significantly impact Sanofi ADR's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2007-02-13
2006-12-310.590.660.0711 
2021-07-29
2021-06-300.750.830.0810 
2018-04-27
2018-03-310.690.770.0811 
View All Earnings Estimates

Sanofi ADR Environmental, Social, and Governance (ESG) Scores

Sanofi ADR's ESG score is a quantitative measure that evaluates Sanofi ADR's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Sanofi ADR's operations that may have significant financial implications and affect Sanofi ADR's stock price as well as guide investors towards more socially responsible investments.

Sanofi ADR Thematic Classifications

In addition to having Sanofi ADR stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Giant Impact Idea
Giant Impact
Public companies with mega capitalization
Compulsion Idea
Compulsion
Addiction driven consumer products and services
Dividend Beast Idea
Dividend Beast
Solid, dividend-paying stocks and ETFs
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Sanofi Stock Institutional Investors

Shares
Goldman Sachs Group Inc2024-09-30
3.7 M
Nuveen Asset Management, Llc2024-09-30
3.6 M
Mondrian Investment Partners Ltd2024-09-30
3.5 M
Franklin Resources Inc2024-09-30
3.4 M
Federated Hermes Inc2024-09-30
3.3 M
Envestnet Asset Management Inc2024-09-30
3.1 M
Boston Partners Global Investors, Inc2024-09-30
2.9 M
Natixis Advisors, Llc.2024-09-30
2.9 M
Raymond James & Associates2024-09-30
2.8 M
Dodge & Cox2024-09-30
76.3 M
Morgan Stanley - Brokerage Accounts2024-09-30
17.8 M
Note, although Sanofi ADR's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sanofi Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 137.26 B.

Sanofi Profitablity

The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.12  0.14 
Return On Capital Employed 0.09  0.17 
Return On Assets 0.05  0.08 
Return On Equity 0.08  0.13 

Management Efficiency

Sanofi ADR has Return on Asset of 0.0437 % which means that on every $100 spent on assets, it made $0.0437 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0753 %, implying that it generated $0.0753 on every 100 dollars invested. Sanofi ADR's management efficiency ratios could be used to measure how well Sanofi ADR manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.14 in 2025. Return On Capital Employed is likely to rise to 0.17 in 2025. At this time, Sanofi ADR's Other Current Assets are fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.14 in 2025, whereas Total Assets are likely to drop slightly above 88.7 B in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 53.46  29.51 
Tangible Book Value Per Share 0.58  0.65 
Enterprise Value Over EBITDA 11.70  13.99 
Price Book Value Ratio 1.75  3.41 
Enterprise Value Multiple 11.70  13.99 
Price Fair Value 1.75  3.41 
Enterprise Value86.5 B64.5 B
Leadership effectiveness at Sanofi ADR is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.0374
Operating Margin
0.1399
Profit Margin
0.1297
Forward Dividend Yield
0.0374
Beta
0.459

Technical Drivers

As of the 16th of February 2025, Sanofi ADR has the Semi Deviation of 1.2, risk adjusted performance of 0.0528, and Coefficient Of Variation of 1493.98. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sanofi ADR, as well as the relationship between them.

Sanofi ADR Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sanofi ADR middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sanofi ADR. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Sanofi ADR Outstanding Bonds

Sanofi ADR issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sanofi ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sanofi bonds can be classified according to their maturity, which is the date when Sanofi ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Sanofi ADR Predictive Daily Indicators

Sanofi ADR intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sanofi ADR stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Sanofi ADR Corporate Filings

14th of February 2025
Other Reports
ViewVerify
6K
13th of February 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
7th of February 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
3rd of February 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
30th of January 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
24th of January 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
14th of January 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
23rd of December 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify

Sanofi ADR Forecast Models

Sanofi ADR's time-series forecasting models are one of many Sanofi ADR's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sanofi ADR's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Sanofi Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sanofi ADR prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sanofi shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sanofi ADR. By using and applying Sanofi Stock analysis, traders can create a robust methodology for identifying Sanofi entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.18  0.21 
Operating Profit Margin 0.15  0.22 
Net Profit Margin 0.11  0.12 
Gross Profit Margin 0.69  0.79 

Current Sanofi Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sanofi analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sanofi analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
63.06Strong Buy8Odds
Sanofi ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Sanofi analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sanofi stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sanofi ADR, talking to its executives and customers, or listening to Sanofi conference calls.
Sanofi Analyst Advice Details

Sanofi Stock Analysis Indicators

Sanofi ADR stock analysis indicators help investors evaluate how Sanofi ADR stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sanofi ADR shares will generate the highest return on investment. By understating and applying Sanofi ADR stock analysis, traders can identify Sanofi ADR position entry and exit signals to maximize returns.
Begin Period Cash Flow12.7 B
Long Term Debt14.3 B
Common Stock Shares Outstanding1.3 B
Total Stockholder Equity74 B
Tax Provision1.6 B
Quarterly Earnings Growth Y O Y0.115
Property Plant And Equipment Net11.8 B
Cash And Short Term Investments8.7 B
Cash8.7 B
Accounts Payable7.3 B
Net Debt9.7 B
50 Day M A50.2294
Total Current Liabilities24.2 B
Other Operating Expenses38.2 B
Non Current Assets Total95.8 B
Forward Price Earnings12.8205
Non Currrent Assets Other588 M
Stock Based Compensation283 M

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.